Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

ock will only be made pursuant to the tender offer statement (including the offer to purchase, the letter of transmittal and other offer documents), which was initially filed with the SEC on September 12, 2008 and will be amended to reflect the terms of King's amended offer pursuant to the terms of the merger agreement. The amended offer isscheduled to expire at 5:00 p.m., New York Citytime, on Friday, December 19, 2008, unless extended. If the amended offer is extended, King will notify the depositary for the offer and issue a press release announcing the extension on or before 9:00 a.m., New York City time, on the first business day following the date the offer was scheduled to expire.

Investors and security holders are urged to read the tender offer statement (including the offer to purchase, the letter of transmittal and other offer documents) and any amendments or supplements thereto and any other documents relating to the tender offer that are filed with the SEC carefully and in their entirety because they contain important information. Investors and security holders can obtain free copies of any such documents filed with the SEC by King at www.kingpharm.com and through the web site maintained by the SEC at www.sec.gov. Free copies of any such documents (when available) can also be obtained by directing a request to King's information agent, Innisfree M&A Incorporated, at (877) 687-1875.

In connection with the tender offer by King, Alpharma has filed with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9, which Alpharma will be amending pursuant to the terms of its merger agreement with King. Alpharma stockholders should read carefully the Solicitation/Recommendation Statement on Schedule 14D-9 (including any amendments or supplements thereto)
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Dennis Thompson HealthDay ... -- A combination drug therapy aimed at opening the ... treatment for older adults with chronic obstructive pulmonary disease ... COPD patients who received a combination of ... to die or require hospitalization because of their breathing ...
(Date:9/16/2014)... Florida (PRWEB) September 16, 2014 Novatus, ... opened a new office in London, UK, and appointed ... accounts in Europe, the expansion will allow Novatus to ... of its European customers. , “Novatus ... market, and London is an ideal location to establish ...
(Date:9/16/2014)... One in five American men admits to using ... survey shows. A nationally representative study from ... is more prevalent than diabetes. This violence includes ... hitting, kicking, biting, choking, burning or threatening their ... Although abuse by high-profile professional athletes has recently ...
(Date:9/16/2014)... Boston University School of Medicine researcher Dr. Jeffrey ... University were recently awarded a five year, $5 ... Abuse for their project titled: Improving Physician Opioid ... Prescription opioids are the second most commonly abused ... deaths related to prescription opioids now exceed deaths ...
(Date:9/16/2014)... London, UK (PRWEB) September 16, 2014 ... paediatric clinical trials has risen considerably in line with ... USA, over 350 product labels include novel paediatric information ... safety review. In the European countries, there has been ... medicinal products from the submission of old or new ...
Breaking Medicine News(10 mins):Health News:Combo Therapy Best for COPD: Study 2Health News:Combo Therapy Best for COPD: Study 3Health News:Novatus Expands European Operations with a New Office in London 2Health News:1 in 5 U.S. Men Admits to Violence Against Spouse, Partner 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 3
... Less Than One in Five Employers Offer Stand Alone Vision ... VSP(R) Vision Care launched the industry,s first ... it grow to more than 25,000 members nationwide. In a ... economy on health and vision care priorities and costs, VSP ...
... Company,s Portable 4.5kg "Lab in a Box" Allows for Rapid ... 9 DxNA announced today that it has submitted a ... its GeneSTAT(R) pathogen platform, for the detection of the H1N1 ... early availability of important diagnostic and therapeutics tools to diagnose, ...
... GeoFitness,s main goal has been to get Americans up ... and curriculum. Their ability to provide solutions to the ... has provided unprecedented growth. The name change to GeoMotion ... include 3 distinct product lines which can interact to offer ...
... , The Rx.com Electronic Pharmacy Record (EPR) to Integrate ... June 9 PDX and Rx.com have entered into ... which Rx.com manages for multiple chain and independent pharmacy ... single site with aggregated prescription data. The agreement enables ...
... NEW YORK, June 9 United Spinal Association ( ... Island ( www.IndependenceExpo.org ) , the region,s ... for individuals with disabilities and aging Americans. , ... 27th & Sunday, June 28th at the Suffolk Community College ...
... proprietary NeuroTrans(TM) technology , , NOVATO, Calif., June ... (OTC Bulletin Board: RPTP), today announced that it has ... (SWX: ROG.VX; RO.S, OTCQX: RHHBY) to evaluate therapeutic ... proprietary NeuroTrans(TM) BBB transporter platform. Under terms of the ...
Cached Medicine News:Health News:VSP's Individual Plan Thrives in a Starving Economy 2Health News:VSP's Individual Plan Thrives in a Starving Economy 3Health News:DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 2Health News:DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 3Health News:GeoFitness, Inc. is Now GeoMotion Group, an Innovative and Fast Growing Learning and Fitness Company for All Ages 2Health News:PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 2Health News:PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 3Health News:United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging 2Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 2Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 3Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 4Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 5
(Date:9/16/2014)... , Sept. 16, 2014  Denovo Biopharma, LLC, ... late-stage oncology drug, from Eli Lilly and Company ... manufacture and commercialize enzastaurin globally, including transfer of ... information. Lilly developed enzastaurin in ... and Phase 3 clinical trials for diffuse large ...
(Date:9/16/2014)... Russia,s pharmaceutical market ... 2020 Strategy provides incentives for local producers to develop ... markets. These trends, however, were affected by recent developments ... and economic sanctions imposed on Russia ... Russia responded to the US and ...
(Date:9/16/2014)...   Evana Automation Specialists , a leading Systems ... systems, recently received a contract to provide a robotic ... Evana solution will help error-proof the process of assembling ... reduce labor. A catheter adapter, connector ... cell. The robot will pick the adapter, connector and ...
Breaking Medicine Technology:Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2Global Medicines for Russia 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3
... CardioGenics Holdings Inc. (CGNH.OB) announced today the transfer ... ultra sensitive magnetic beads for use in diagnostic ... beads business unit, which was previously operated out ... will now be operated exclusively out of Luxspheres, ...
... SAN FRANCISCO, June 22, 2011 Vista Partners ... Pharmaceuticals, Inc. (AMEX: ANX ) ("The Company" ... Ross Silver, Principal Analyst at Vista Partners stated, “ANX has ... that could serve multi-billion dollar markets and one candidate with ...
Cached Medicine Technology:CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary 2CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary 3Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50 2
... dual-monochromator, multi-detection microplate reader with a ... reading capability. Detection modalities include absorbance ... and have optical performance comparable to ... Endpoint, kinetic, spectrum and area-well scanning ...
... of PCR, cDNA and Oligonucleotides The ... for a variety applications that are quantified by ... to handle assays in Microplate formats from ... Cuvettes Independent whether you have ...
... High Throughput Screening (HTS), Analyst HT ... HTS by sharing all the detection ... AD, fluorescence intensity, fluorescence polarization, time-resolved ... seamless integration into robotic environments, including ...
... Designed for Ultra High Throughput ... multimode assay detection performance. Allows for ... from assay development by sharing all ... and HT, fluorescence intensity, fluorescence polarization, ...
Medicine Products: